FR2875231B1 - Nouveaux derives de 1,3,5-triazepine-2,4-diones, leur procede de preparation et les compositions pharmaceutiques les contenant - Google Patents

Nouveaux derives de 1,3,5-triazepine-2,4-diones, leur procede de preparation et les compositions pharmaceutiques les contenant

Info

Publication number
FR2875231B1
FR2875231B1 FR0409758A FR0409758A FR2875231B1 FR 2875231 B1 FR2875231 B1 FR 2875231B1 FR 0409758 A FR0409758 A FR 0409758A FR 0409758 A FR0409758 A FR 0409758A FR 2875231 B1 FR2875231 B1 FR 2875231B1
Authority
FR
France
Prior art keywords
triazepine
novel
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0409758A
Other languages
English (en)
Other versions
FR2875231A1 (fr
Inventor
Pascale Clivio
Frederic Peyrane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0409758A priority Critical patent/FR2875231B1/fr
Publication of FR2875231A1 publication Critical patent/FR2875231A1/fr
Application granted granted Critical
Publication of FR2875231B1 publication Critical patent/FR2875231B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0409758A 2004-09-15 2004-09-15 Nouveaux derives de 1,3,5-triazepine-2,4-diones, leur procede de preparation et les compositions pharmaceutiques les contenant Expired - Fee Related FR2875231B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0409758A FR2875231B1 (fr) 2004-09-15 2004-09-15 Nouveaux derives de 1,3,5-triazepine-2,4-diones, leur procede de preparation et les compositions pharmaceutiques les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409758A FR2875231B1 (fr) 2004-09-15 2004-09-15 Nouveaux derives de 1,3,5-triazepine-2,4-diones, leur procede de preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
FR2875231A1 FR2875231A1 (fr) 2006-03-17
FR2875231B1 true FR2875231B1 (fr) 2006-12-01

Family

ID=34949866

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0409758A Expired - Fee Related FR2875231B1 (fr) 2004-09-15 2004-09-15 Nouveaux derives de 1,3,5-triazepine-2,4-diones, leur procede de preparation et les compositions pharmaceutiques les contenant

Country Status (1)

Country Link
FR (1) FR2875231B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114436983B (zh) * 2021-11-23 2023-05-23 辽宁中医药大学 马齿苋中Oleraze和Oleraoxazine acid及其提取分离方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275057A (en) * 1980-01-28 1981-06-23 The United States Of America As Represented By The Department Of Health, Education And Welfare Seven-membered ring compounds as inhibitors of cytidine deaminase

Also Published As

Publication number Publication date
FR2875231A1 (fr) 2006-03-17

Similar Documents

Publication Publication Date Title
FR2827604B1 (fr) Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
FR2816938B1 (fr) Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
FR2903101B1 (fr) Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA27411A1 (fr) Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA27410A1 (fr) Nouveaux composes pyridopyrimidinone leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA26740A1 (fr) Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2866647B1 (fr) Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA27297A1 (fr) NOUVEAUX DERIVES D'INDOLIZINE 1,2,3 SUBSTITUEE, INHIBITEURS DES FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
FR2859997B1 (fr) Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2883876B1 (fr) Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885616B1 (fr) Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2881138B1 (fr) Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2872164B1 (fr) Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2907451B1 (fr) "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
MA27407A1 (fr) Nouveaux derives de 2,3-dihydro-4(1h)-pyridinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885615B1 (fr) Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2893616B1 (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
FR2877338B1 (fr) Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA29223B1 (fr) Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2853649B1 (fr) Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2870538B1 (fr) Nouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857665B1 (fr) Nouveaux derives de flavones, leur procede de preparation et compositions pharmaceutiques les contenant
FR2907452B1 (fr) "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
FR2875231B1 (fr) Nouveaux derives de 1,3,5-triazepine-2,4-diones, leur procede de preparation et les compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150529